Skip to main content
. 2023 Jan 6;10:1002837. doi: 10.3389/fpubh.2022.1002837

Table 1.

Description and comparison of patient demographic and clinical characteristics.

Depression cases and controls Anxiety cases and controls
Depression
(n = 102)
Controls
(n = 206)
P Anxiety
(n = 92)
Controls
(n = 206)
P
Age (ye) 58.7 ± 9.0 57.4 ± 10.1 0.263 58.6 ± 9.4 57.4 ± 10.1 0.368
Gender 0.034 0.027
Male [n (%)] 51 (50.0) 129 (62.6) 45 (48.9) 129 (62.6)
Female [n (%)] 51 (50.0) 77 (37.4) 47 (51.1) 77 (37.4)
Educational level 0.017 0.047
Primary [n (%)] 29 (28.4) 32 (15.5) 25 (27.2) 32 (15.5)
Junior [n (%)] 34 (33.3) 64 (31.1) 31 (33.7) 64 (31.1)
Senior [n (%)] 30 (29.4) 74 (35.9) 27 (29.3) 74 (35.9)
University [n (%)] 9 (8.8) 36 (17.5) 9 (9.8) 36 (17.5)
Occupation type < 0.001 < 0.001
Intellectual [n (%)] 28 (27.5) 106 (51.5) 25 (27.2) 106 (51.5)
Physical [n (%)] 74 (72.5) 100 (48.5) 67 (72.8) 100 (48.5)
Hypertension [n (%)] 53 (52.0) 85 (41.3) 0.076 47 (51.1) 85 (41.3) 0.115
Diabetes mellitus [n (%)] 28 (27.5) 41 (19.5) 0.135 27 (29.3) 41 (19.5) 0.073
Cardiovascular disease [n (%)] 12 (11.8) 19 (9.2) 0.487 10 (10.9) 19 (9.2) 0.658
Cerebrovascular diseases [n (%)] 16 (15.7) 24 (11.4) 0.321 15 (16.3) 24 (11.4) 0.271
CCI 2 (1, 3) 1 (0, 2) 0.002 2 (1, 3) 1 (0, 2) 0.004
CCI (category) 0.004 0.004
≤ 1 point 48 (47.1) 126 (61.2) 44 (47.8) 126 (61.2)
2 points 19 (18.6) 44 (21.4) 16 (17.4) 44 (21.4)
≥3 points 35 (34.3) 36 (17.5) 32 (34.8) 36 (17.5)
BMI (kg/m2) 25.2 ± 3.3 25.5 ± 3.5 0.551 25.1 ± 3.4 25.5 ± 3.5 0.454
BMI (WHO-Asian category) 0.770 0.772
Normal [n (%)] 29 (28.4) 51 (24.8) 27 (29.3) 51 (24.8)
Overweight [n (%)] 47 (46.1) 102 (49.5) 42 (45.7) 102 (49.5)
Obese [n (%)] 26 (25.5) 53 (25.7) 23 (25.0) 53 (25.7)
Smoke [n (%)] 30 (29.4) 65 (31.6) 0.702 28 (30.4) 65 (31.6) 0.847
Drink [n (%)] 24 (23.5) 51 (24.3) 0.813 19 (20.7) 51 (24.3) 0.440
Symptom duration (mo) 30 (5, 72) 12 (4, 48) 0.155 24 (4.5, 66) 12 (4, 48) 0.290
Symptom duration (category) 0.039 0.111
< 1 year 43 (42.2) 108 (52.4) 39 (42.4) 108 (52.4)
1–5 years 31 (30.4) 66 (32.1) 30 (32.6) 66 (32.1)
>5 years 28 (27.5) 32 (15.5) 23 (25.0) 32 (15.5)
Pre-operative symptomatology 0.001 0.002
Radiculopathy [n (%)] 14 (13.7) 60 (29.1) 13 (14.1) 60 (29.1)
Myelopathy [n (%)] 38 (37.7) 83 (40.3) 33 (35.9) 83 (40.3)
Myeloradiculopathy [n (%)] 50 (49.0) 63 (30.6) 46 (50.0) 63 (30.6)
Surgery history 0.032 0.016
Primary surgery [n (%)] 91 (89.2) 197 (95.6) 81 (88.0) 197 (95.6)
Revision surgery [n (%)] 11 (10.8) 9 (4.4) 11 (12.0) 9 (4.4)
NDI 29 (10.0, 42.0) 17 (8.0, 29.5) < 0.001 30 (14.0, 44.0) 17 (8.0, 29.5) < 0.001
NDI (category) < 0.001 < 0.001
No disability [n (%)] 25 (24.5) 67 (32.5) 21 (22.8) 67 (32.5)
Mild disability [n (%)] 26 (25.5) 89 (43.2) 22 (23.9) 89 (43.2)
Moderate disability [n (%)] 33 (32.4) 41 (19.9) 32 (34.8) 41 (19.9)
Severe disability [n (%)] 18 (17.6) 9 (4.4) 17 (18.5) 9 (4.4)
mJOA 12 (10.5, 14.0) 14 (13.0, 15.5) < 0.001 12 (10.0, 14.0) 14 (13.0, 15.5) < 0.001
mJOA (category) < 0.001 < 0.001
Mild myelopathy [n (%)] 17 (16.7) 93 (45.1) 14 (15.2) 93 (45.1)
Moderate myelopathy [n (%)] 39 (38.2) 80 (38.8) 32 (34.8) 80 (38.8)
Severe myelopathy [n (%)] 46 (45.1) 33 (16.0) 46 (50.0) 33 (16.0)
VAS-neck 4 (0, 6) 2 (0, 4) < 0.001 4 (1, 6) 2 (0, 4) < 0.001
VAS-arm 4 (0, 6) 3 (0, 6) 0.020 4 (0, 6) 3 (0, 6) 0.017

Data are expressed as either the mean value ± standard deviation, median and range (25th and 75th percentiles), or frequency (%) of patients. Independent sample t-tests, Mann-Whitney U-tests, or chi-square tests were used for univariate analyses. CCI, Charlson comorbidity index; BMI, body mass index; NDI, Neck Disability Index; mJOA, modified Japanese Orthopedic Association score; VAS, Visual Analog Scale; SDS, Self-Rating Depression Scale; SAS, Self-Rating Anxiety Scale; SF-36, 36-item Short-form Health Survey; PCS, physical component summary score; MCS, mental component summary score.Non-parametric variables. The bold values indicate the values of p < 0.05.